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Abstract
Introduction: Psammocarcinoma of ovary is a rare serous neoplasm characterized by extensive
formation of psammoma bodies, invasion of ovarian stroma, peritoneum or intraperitoneal viscera,
and moderate cytological atypia. Extensive medlar search showed presence of only 28 cases of
psammocarcinoma of ovary reported till date.
Case presentation: We herein report a case of psammocarcinoma of ovary with serous
cystadenofibroma of contralateral ovary in a 55 year old Asian Indian female.
Conclusion: To the best of author's knowledge, ours is the rare case describing coexistence of
this very rare malignant serous epithelial tumor with a benign serous cystadenofibroma of
contralateral ovary.
Introduction
Psammocarcinoma of ovary is a rare serous neoplasm.
Diagnosis requires the psammoma bodies to be present in
at least 75% of papillae which show a destructive invasion
of the ovarian stroma. The neoplastic cells do not show
more than moderate atypia. There should be no areas of
solid proliferation of neoplastic cells. These tumors are
associated with a better prognosis than conventional
serous neoplasms with low recurrence following tumor
resection [1]. Literature search showed presence of only
28 cases of psammocarcinoma of ovary reported till date
(Table 1) [1-17]. This case will be another new one in the
literature with serous cystadenofibroma of contralateral
ovary and elevated levels of CA-125.
Case presentation
A 55-year-old Asian Indian female presented to gynecol-
ogy clinic with complaints of menorrhagia, abdominal
discomfort and pain. On Examination a mass was palpa-
ble in the lower abdomen which was non tender and
fixed. Ultrasound (USG) examination revealed the pres-
ence of an abdomino-pelvic mass and ascites. Contrast-
enhanced computed tomogram (CECT) revealed an
abdominopelvic lobulated calcified mass measuring 17 ×
15 × 16 cms (Fig 1a). Clinically, a possibility of calcified
fibroid of uterus was suspected. However, cytologic exam-
ination of ascitic fluid was positive for malignant cells. On
exploratory laparotomy, bilateral ovaries were enlarged
with intact capsule. Total abdominal hysterectomy with
bilateral salpingo-oophorectomy was performed. There
were no retroperitoneal lymph nodes. No visible tumor
nodules were identified on peritoneal surface. Grossly the
left ovary was enlarged and measuring 24 × 20 × 20 cms.
Outer surface was smooth and lobulated. Cut section was
solid, grey white, gritty and granular with no visible necro-
sis (Fig 1b). The right ovary measured 7 × 6 × 2 cms. Cut
Published: 15 December 2009
Journal of Medical Case Reports 2009, 3:9330 doi:10.1186/1752-1947-3-9330
Received: 19 September 2009
Accepted: 15 December 2009
This article is available from: http://www.jmedicalcasereports.com/content/3/1/9330
© 2009 Jain et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.J
o
u
r
n
a
l
 
o
f
 
M
e
d
i
c
a
l
 
C
a
s
e
 
R
e
p
o
r
t
s
 
2
0
0
9
,
 
3
:
9
3
3
0
h
t
t
p
:
/
/
w
w
w
.
j
m
e
d
i
c
a
l
c
a
s
e
r
e
p
o
r
t
s
.
c
o
m
/
c
o
n
t
e
n
t
/
3
/
1
/
9
3
3
0
P
a
g
e
 
2
 
o
f
 
6
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: Literature review of primary ovarian psammocarcinomas
Author Year No. of
cases
Age Clinical features CA- 125 
units/ml
FIGO 
stage
Surgery Chemothearpy Follow up Remarks
Gilks et al [1] 1990 8 36 to 76 
(mean of 57)
Abdominal pain NA III TAH+ BSO 
(4 cases)
LSO(2 cases)
BSO(2 cases)
Oment 
(3/8 cases)
Y 
(1 patient)
1-died
3- lost FU
4- free of disease
Kelley et al [2] 1995 1 18 Abdominal pain 25 IIIC TAH, BSO, oment, Y 42 months NED Adolescent
Pakos et al [3] 
(German)
1997 1 49 Mass in the lower 
abdomen
IA BSO N NED
Powell et al [4] 1998 1 59 Abdominal pain and 
increasing abdominal 
girth
118 IIIB TAH, BSO, oment N 12 months NED Family history of 
epithelial cancer positive
Poggi et al [5] 1998 1 66 Abdominal Pain 
nausea vomiting
NA IIIB BSO, oment N Recurrence 18 
months
Aggressive, with 
Cystadenofibromata
Cobellis et al [6] 2003 1 48 Referred for 
leiomyomata uteri
Normal IIIA TAH, BSO, oment N 2 years NED Omental and peritoneal 
implant
Giordano et al [7] 2005 1 66 Abdomino-pelvic 
mass
Elevated IIIB TAH, BSO, oment, Y NED after 1 year Bilateral, omental 
nodule showed the 
features of invasive 
implant
Rattenmaier et al [8] 2005 1 70 Malaise and 
abdominal 
discomfort
25,000 NA AH, BSO N Recovered Bilateral with 
cysadenofibromata
Radin et al [9] 2005 1 60 Diffuse abdominal 
pain, bloating, 
diarrhea, and low 
back pain,
65.2 III Laparotomy, tumor 
debulking
Y NA Aggressive
Vimplis et al[10] 2006 1 63 Abdominal 
discomfort and 
increasing abdominal 
girth
1,133 IIIB BSO,, SH, oment, Y NED
Hiromura et al [11] 2007 1 73 Lower abdominal 
distention and pain
464 IIIC AH, BSO, and oment Y 4 months stableJ
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Akbulut et al [12] 2007 1 67 Vaginal bleeding and 
abdomino-pelvic pain
175 IIIC Debulking Y 10 years with 
recurrent and 
metastatic disease
Aggressive
Pusiol et al [13] 2008 1 50 NA NA IIIB Laparotomy Y 10.5 years, free of 
disease.
Bilateral, psammoma 
bodies in cervical smear, 
Presence of 
psammocarcinoma
in the tubaric lumen
Alanbay et al [14] 2009 2 41,50 Adnexal mass, pelvic 
pain
NA, 3,223 III Surgery Y 6 years free of 
disease, 2 months
Tiro et al [15] 2009 1 58 Shortness of breath 175.5 NA N Y NA Implants in pleural cavity 
and pericardium
Chase et al [16] 2009 1 45 Subcutaneous nodule NA NA Bilateral salpingo-
oophrectomy
Tamoxifen NA Mediastinal, pulmonary, 
subcutaneous, and 
omental metastases
Poujade et al [17] 2009 4 19-67 NA NA NA Y Y except in one 
case
18-45 months 
NED, one case has 
persistent disease
Current case 2009 1 50 Menorrhagia, 
abdominal 
discomfort and pain
995.4 I C Total abdominal 
hysterectomy with 
bilateral salpingo 
oophorectomy
Y 6 months, free of 
disease
Contralteral 
cystadenofibroma
Abbreviations: NA- Not available; TAH - Total abdominal hysterectomy; BSO- Bilateral salpingo- oophorectomy; Oment- Omentectomy; AH- Abdominal hysterectomy; Y- Yes; N- No; FU- Follow up; NED- 
No evidence of disease, LSO - left salpingo-oophorectomy; SH- Subtotal hysterectomy
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section was solid and cystic with cysts ranging in size from
0.4 to 0.5 cm. The cysts were filled with clear fluid. No
areas of hemorrhage or necrosis were seen in either of the
two ovaries. Microscopically, sections from the left ovary
revealed numerous psammoma bodies infiltrating the
ovarian stroma and forming more than 95% of the tumor.
At places these were lined by low cuboidal cells with min-
imal atypia (Fig 1c-f). No areas of necrosis, hemorrhage or
increase mitosis were seen. Sections from the right ovary
showed cysts lined by low cuboidal epithelium with
prominence of fibroblastic stromal component. Thus a
final diagnosis of psammocarcinoma of left ovary and
serous cystadenofibroma of right ovary was made. Follow-
ing the diagnosis, serum CA-125 was estimated which was
elevated to 995.4 U/ml. Uterus showed a submucosal lei-
omyoma with proliferative endometrium on histology.
Cervix and bilateral fallopian tubes were unremarkable
grossly as well as microscopically. Patient received chem-
otherapy and kept on close follow up.
Discussion
Psammocarcinoma of ovary is a rare serous neoplasm
which can arise from both peritoneum and ovaries [1].
Extensive search showed presence of only 28 cases of
psammocarcinoma of ovary reported till date [1-17]
(Table 1). Age ranged from 18 to 76 years [1,2]. Many of
these cases presented with abdominal discomfort and
increasing abdominal girth.
This tumor can be misdiagnosed as other calcifying
tumors of abdomino-pelvic region especially calcified lei-
omyomas, by radiological investigations, similar to our
case. However if calcified abdomino-pelvic tumors are
seen in association with an elevated CA-125 level, then a
diagnosis of ovarian neoplasm can be made [7]. In most
of the reported cases CA-125 levels were raised ranging
from 65-25,000 units/ml [7,8]. Our patient had elevated
levels of CA-125 just after the surgery.
Although most of the cases reported are unilateral, rarely
these are bilateral [8,13].
All but one, cases reported in the literature had FIGO stage
III tumors showing clinical behavior similar to that of bor-
derline serous tumors [3]. Our case fits in to stage I C as
patient had malignant ascitis, however no pelvic exten-
sion was seen.
Despite the apparent low malignant potential of this
tumor, there remains a need for patient's follow up data
as aggressive behavior has been described in the literature
[12,15,16]. In the case reported by Poggi et al [5] no adju-
vant therapy was given because of the supposed indolent
Computed tomography scan shows calcified abdominopelvic mass (a); gross photograph shows gritty and firm tumor (b); on  histological examination, tumor reveals extensive psammoma bodies which are surrounded by single layer of cytologically bland  cuboidal or low columnar epithelium (c-f) H&E cx40; dx100; ex400; fx600 Figure 1
Computed tomography scan shows calcified abdominopelvic mass (a); gross photograph shows gritty and firm 
tumor (b); on histological examination, tumor reveals extensive psammoma bodies which are surrounded by 
single layer of cytologically bland cuboidal or low columnar epithelium (c-f) H&E cx40; dx100; ex400; fx600.Journal of Medical Case Reports 2009, 3:9330 http://www.jmedicalcasereports.com/content/3/1/9330
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behavior. However, recurrence of disease has been noted
after eighteen months. Our patient received post operative
adjuvant therapy and is on follow up.
Histopathologic differential diagnosis of psammocarci-
noma involves other serous epithelial tumors. Some rare
cystadenofibromas have mild cytologic atypia and may
also exhibit psammoma bodies, but they are generally
inconspicuous. In the present case we have seen cystad-
enofibroma in the contralateral ovary with an occasional
psammoma body formation. Earlier, association of psam-
mocarcinoma with cystadenofibroma has been docu-
mented [5,8]. Although these tumors show clinical
behavior similar to that of borderline serous tumors, the
presence of destructive stromal invasion excludes serous
borderline tumors. Moderate cytologic atypia helps differ-
entiating from high grade serous carcinomas. Psammocar-
cinomas differ from well-differentiated serous
adenocarcinomas by numerous psammoma body forma-
tions.
Potential mechanisms responsible for the characteristic,
extensive psammoma body formation include the accu-
mulation of successive layers of calcium on single necrotic
or degenerated tumor cells. One hypothesis states that
they arise due to accumulation of hydroxyapatite in
degenerating cells [18]. Psammoma bodies are described
as multiple, discrete, laminated calcified bodies and are
found in many neoplastic and non neoplastic lesions.
Characteristic calcifications on radiological investigations
and psammoma bodies on cervicovaginal smears should
alert the clinician for this unusual tumor. Recently Pusiol
et al [13] have reported a case of psammocarcinoma asso-
ciated with presence of psammoma bodies in the cervi-
covaginal smears.
The molecular features of psammocarcinoma include
mutations of a gene belong to the cancer related RAF fam-
ily, that is BRAF [19].
Hiromura et al [11] described imaging features of psam-
mocarcinoma including extensive minute calcifications
on CT scan that were not detected on the abdominal x-ray.
The tumor appears sandy and coarsely granular on
enhanced T1-weighted MR images due to scattered clus-
ters of psammomatous calcifications. Radin et al [9] have
shown its high avidity for the Tc-99m MDP radiopharma-
ceutical.
Like with other serous epithelial tumors of the ovary,
aggressive debulking surgery has been the initial treat-
ment modality in nearly all cases. Postoperative therapies
have included observation, tamoxifen and cytotoxic
chemotherapy (generally using cyclophosphamide with
cisplatin or carboplatin) [4].
Conclusion
Psammocarcinomas are rare serous neoplasms. Due to the
rare aggressive nature of the tumor, it is important to fol-
low up the patient closely. Our case adds a new case of
psammocarcinoma with contralateral cysadenofibroma
in the literature.
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